Suppr超能文献

一种主要识别 N 连接糖基的中和抗体靶向 HIV 包膜的静默面。

A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

出版信息

Immunity. 2018 Mar 20;48(3):500-513.e6. doi: 10.1016/j.immuni.2018.02.013. Epub 2018 Mar 13.

Abstract

Virtually the entire surface of the HIV-1-envelope trimer is recognized by neutralizing antibodies, except for a highly glycosylated region at the center of the "silent face" on the gp120 subunit. From an HIV-1-infected donor, #74, we identified antibody VRC-PG05, which neutralized 27% of HIV-1 strains. The crystal structure of the antigen-binding fragment of VRC-PG05 in complex with gp120 revealed an epitope comprised primarily of N-linked glycans from N262, N295, and N448 at the silent face center. Somatic hypermutation occurred preferentially at antibody residues that interacted with these glycans, suggesting somatic development of glycan recognition. Resistance to VRC-PG05 in donor #74 involved shifting of glycan-N448 to N446 or mutation of glycan-proximal residue E293. HIV-1 neutralization can thus be achieved at the silent face center by glycan-recognizing antibody; along with other known epitopes, the VRC-PG05 epitope completes coverage by neutralizing antibody of all major exposed regions of the prefusion closed trimer.

摘要

HIV-1 包膜三聚体的几乎整个表面都可被中和抗体识别,除了 gp120 亚基“静默面”中心高度糖基化的区域。我们从一位 HIV-1 感染者供体#74 中鉴定出了抗体 VRC-PG05,它能中和 27%的 HIV-1 株系。VRC-PG05 的抗原结合片段与 gp120 复合物的晶体结构揭示了一个主要由静默面中心 N262、N295 和 N448 的 N 连接聚糖组成的表位。抗体与这些糖基相互作用的残基上发生了体细胞超突变,提示了糖基识别的体细胞发育。供体#74 中对 VRC-PG05 的耐药性涉及糖基-N448 向 N446 的转移或糖基近端残基 E293 的突变。因此,糖基识别抗体可在静默面中心实现 HIV-1 的中和;加上其他已知的表位,VRC-PG05 表位完成了中和抗体对融合前封闭三聚体所有主要暴露区域的全覆盖。

相似文献

8
Antibody responses to the HIV-1 envelope high mannose patch.HIV-1 包膜高甘露糖补丁的抗体反应。
Adv Immunol. 2019;143:11-73. doi: 10.1016/bs.ai.2019.08.002. Epub 2019 Sep 11.

引用本文的文献

2
Current methods for detecting and assessing HIV-1 antibody resistance.检测和评估HIV-1抗体耐药性的当前方法。
Front Immunol. 2025 Jan 6;15:1443377. doi: 10.3389/fimmu.2024.1443377. eCollection 2024.
8
Broadly neutralizing antibodies targeting HIV: Progress and challenges.广谱中和抗体靶向 HIV:进展与挑战。
Clin Immunol. 2023 Dec;257:109809. doi: 10.1016/j.clim.2023.109809. Epub 2023 Oct 16.
10
Adjuvants influence the maturation of VRC01-like antibodies during immunization.佐剂在免疫过程中影响VRC01样抗体的成熟。
iScience. 2022 Nov 2;25(11):105473. doi: 10.1016/j.isci.2022.105473. eCollection 2022 Nov 18.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验